\-\ Texto\\:\\ \ \(0\)\
\-\ bronchial\\ washings\\ \\-\\ no\\ malignant\\ cells\\,\\ no\\ eosinophilia\\,\\ no\\ organisms\\ isolated\ \(0\)\
\-\ steroids\\ as\\ above\ \(0\)\
\-\ several\\ axial\\ ct\\ images\\ demonstrate\\ patchy\\ bilateral\\ consolidations\\ along\\ the\\ bronchovascular\\ bundles\\ with\\ diffuse\\ ground\\ glass\\.\\ \ \(0\)\
\-\ conventional\\ chest\\ radiographs\\ show\\ improvement\\ in\\ the\\ disease\\ process\\ in\\ 48\\ hours\\ after\\ steroid\\ administration\\.\ \(0\)\
\-\ boop\\/cop\ \(0\)\
\-\ atypical\\ infectious\\ etiologies\\ to\\ include\\ fungal\\/tb\ \(0\)\
\-\ sarcoid\ \(163\)\
\-\ bronchoalveolar\\ carcinoma\ \(5\)\
\-\ eosinophilic\\ pneumonia\ \(5\)\
\-\ cryptogenic\\ organizing\\ pneumonia\\ \\(cop\\ \\-\\ previously\\ boop\\)\ \(0\)\
\-\ low\\ grade\\ fever\\ with\\ cough\ \(0\)\
\-\ histologic\\ diagnosis\\:\\(masson\\ cells\\ \\â\\€\\“granulation\\ tissue\\ plugs\\ in\\ the\\ bronchioles\\)\ \(0\)\
\-\ etiologies\\ include\\ drugs\\,\\ post\\ infectious\\,\\ toxic\\ inhalational\\,\\ cryptogenic\ \(0\)\
\-\ \\(40\\-60\\,\\ no\\ sex\\ predilection\\)\ \(1\)\
\-\ elevated\\ esr\\ \\(\\>60\\)\\ in\\ 30\\%\\ of\\ patients\ \(0\)\
\-\ clinically\\ \\â\\€\\“\\ cough\\ and\\ low\\ grade\\ fever\ \(0\)\
\-\ no\\ improvement\\ with\\ antibiotics\ \(0\)\
\-\ ct\\ findings\\:\ \(0\)\
\-\ patchy\\ consolidations\\ in\\ subpleural\\ or\\ peribronchial\\ distribution\\,\\ ground\\ glass\ \(0\)\
\-\ may\\ present\\ with\\ centrilobular\\ nodules\\,\\ adenopathy\\,\\ or\\ effusions\\ \\(approx\\ 30\\%\\)\ \(0\)\
\-\ reverse\\ halo\\ \\(ground\\ glass\\ surrounded\\ by\\ consolidation\\ \\â\\€\\“\\ 30\\%\\)\ \(0\)\
\-\ differential\\:\\ atypical\\ infections\\,\\ tb\\,\\ mai\\,\\ sarcoid\\,\\ bac\\,\\ eosinophilic\\ pneumonia\\,\\ lymphoma\ \(0\)\
\-\ relapses\\ are\\ common\\ after\\ cessation\\ of\\ steroid\\ therapy\\ and\\ the\\ consolidations\\ may\\ persist\\ despite\\ therapy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ consolidations\\:\\ 0\\.3019390357002152\ \(0\)\
\-\ glass\\:\\ 0\\.21592538089310617\ \(0\)\
\-\ cop\\:\\ 0\\.211464438330193\ \(0\)\
\-\ ground\\:\\ 0\\.2089584849345785\ \(0\)\
\-\ boop\\:\\ 0\\.2058665215281818\ \(0\)\
\-\ cryptogenic\\:\\ 0\\.20129269046681011\ \(0\)\
\-\ pneumonia\\:\\ 0\\.16942726602165292\ \(0\)\
\-\ 30\\:\\ 0\\.14643350690343776\ \(0\)\
\-\ etiologies\\:\\ 0\\.14352862018909968\ \(0\)\
\-\ patchy\\:\\ 0\\.13930565662305233\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.13930565662305233\ \(0\)\
\-\ steroid\\:\\ 0\\.13793070338708846\ \(0\)\
\-\ sarcoid\\:\\ 0\\.13420734756742486\ \(0\)\
\-\ tb\\:\\ 0\\.12742667759349563\ \(0\)\
\-\ improvement\\:\\ 0\\.12491592220325529\ \(0\)\
\-\ atypical\\:\\ 0\\.11740206573532111\ \(0\)\
\-\ no\\:\\ 0\\.11633882349889511\ \(0\)\
\-\ infectious\\:\\ 0\\.11514556877468192\ \(0\)\
\-\ cells\\:\\ 0\\.11025898866039748\ \(0\)\
\-\ masson\\:\\ 0\\.1093407041460216\ \(0\)\
\-\ mai\\:\\ 0\\.1093407041460216\ \(0\)\
\-\ 60\\:\\ 0\\.10703432767996805\ \(0\)\
\-\ cough\\:\\ 0\\.10683985680708771\ \(0\)\
\-\ plugs\\:\\ 0\\.1057322191650965\ \(0\)\
\-\ relapses\\:\\ 0\\.1057322191650965\ \(0\)\
\-\ washings\\:\\ 0\\.1029332607640909\ \(0\)\
\-\ inhalational\\:\\ 0\\.1029332607640909\ \(0\)\
\-\ grade\\:\\ 0\\.10290364759774549\ \(0\)\
\-\ bac\\:\\ 0\\.10064634523340506\ \(0\)\
\-\ bronchioles\\:\\ 0\\.09703786025247997\ \(0\)\
\-\ fever\\:\\ 0\\.0970257984598402\ \(0\)\
\-\ eosinophilia\\:\\ 0\\.09556047130171362\ \(0\)\
\-\ organizing\\:\\ 0\\.09423890185147436\ \(0\)\
\-\ bronchovascular\\:\\ 0\\.09195198632078852\ \(0\)\
\-\ centrilobular\\:\\ 0\\.09195198632078852\ \(0\)\
\-\ peribronchial\\:\\ 0\\.0900184267902436\ \(0\)\
\-\ reverse\\:\\ 0\\.08915302791978291\ \(0\)\
\-\ halo\\:\\ 0\\.08915302791978291\ \(0\)\
\-\ in\\:\\ 0\\.0889985741190052\ \(0\)\
\-\ bronchoalveolar\\:\\ 0\\.08834350133986342\ \(0\)\
\-\ subpleural\\:\\ 0\\.08834350133986342\ \(0\)\
\-\ bundles\\:\\ 0\\.08686611238909707\ \(0\)\
\-\ sex\\:\\ 0\\.08618793055367233\ \(0\)\
\-\ include\\:\\ 0\\.08514509579725014\ \(0\)\
\-\ predilection\\:\\ 0\\.08274558453785222\ \(0\)\
\-\ therapy\\:\\ 0\\.08222206450011996\ \(0\)\
\-\ low\\:\\ 0\\.08211338584506682\ \(0\)\
\-\ approx\\:\\ 0\\.08178023845740563\ \(0\)\
\-\ persist\\:\\ 0\\.08132406787762707\ \(0\)\
\-\ histologic\\:\\ 0\\.08004737614426548\ \(0\)\
\-\ cessation\\:\\ 0\\.07964914242724688\ \(0\)\
\-\ organisms\\:\\ 0\\.07716775310200136\ \(0\)\
\-\ surrounded\\:\\ 0\\.07355926812107626\ \(0\)\
\-\ conventional\\:\\ 0\\.0730858795447891\ \(0\)\
\-\ toxic\\:\\ 0\\.0730858795447891\ \(0\)\
\-\ bronchial\\:\\ 0\\.07285572063800426\ \(0\)\
\-\ may\\:\\ 0\\.0720140380809224\ \(0\)\
\-\ drugs\\:\\ 0\\.07155697796110203\ \(0\)\
\-\ after\\:\\ 0\\.06942170386114264\ \(0\)\
\-\ isolated\\:\\ 0\\.06800000561309766\ \(0\)\
\-\ effusions\\:\\ 0\\.06696032012639332\ \(0\)\
\-\ consolidation\\:\\ 0\\.06613298898920911\ \(0\)\
\-\ esr\\:\\ 0\\.06548293117562697\ \(0\)\
\-\ infections\\:\\ 0\\.06317491671904633\ \(0\)\
\-\ steroids\\:\\ 0\\.06286261904848547\ \(0\)\
\-\ despite\\:\\ 0\\.062260424602013816\ \(0\)\
\-\ 48\\:\\ 0\\.06196983303071028\ \(0\)\
\-\ distribution\\:\\ 0\\.06069623040178173\ \(0\)\
\-\ adenopathy\\:\\ 0\\.06018764823185279\ \(0\)\
\-\ clinically\\:\\ 0\\.0594614662010082\ \(0\)\
\-\ previously\\:\\ 0\\.05743863007659257\ \(0\)\
\-\ the\\:\\ 0\\.05710854382531971\ \(0\)\
\-\ administration\\:\\ 0\\.056980076875762675\ \(0\)\
\-\ nodules\\:\\ 0\\.056852082821413935\ \(0\)\
\-\ with\\:\\ 0\\.05604278772659374\ \(0\)\
\-\ hours\\:\\ 0\\.05453337181492745\ \(0\)\
\-\ ct\\:\\ 0\\.054480728403109656\ \(0\)\
\-\ process\\:\\ 0\\.05366444508380873\ \(0\)\
\-\ antibiotics\\:\\ 0\\.05271373957518705\ \(0\)\
\-\ above\\:\\ 0\\.05161851473689195\ \(0\)\
\-\ malignant\\:\\ 0\\.05100452715542959\ \(0\)\
\-\ or\\:\\ 0\\.0497830520187649\ \(0\)\
\-\ elevated\\:\\ 0\\.04877767546730556\ \(0\)\
\-\ along\\:\\ 0\\.04793682974880026\ \(0\)\
\-\ several\\:\\ 0\\.0469448659441795\ \(0\)\
\-\ differential\\:\\ 0\\.04649075993661972\ \(0\)\
\-\ radiographs\\:\\ 0\\.0464074153875448\ \(0\)\
\-\ show\\:\\ 0\\.04542259927653548\ \(0\)\
\-\ diffuse\\:\\ 0\\.04487170677678073\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04279893040661971\ \(0\)\
\-\ lymphoma\\:\\ 0\\.042613405617118676\ \(0\)\
\-\ axial\\:\\ 0\\.041330774660898136\ \(0\)\
\-\ common\\:\\ 0\\.040577950250129544\ \(0\)\
\-\ patients\\:\\ 0\\.04025168563954154\ \(0\)\
\-\ post\\:\\ 0\\.03893350673087907\ \(0\)\
\-\ bilateral\\:\\ 0\\.03845446776101604\ \(0\)\
\-\ chest\\:\\ 0\\.03776855793046856\ \(0\)\
\-\ tissue\\:\\ 0\\.03753435426296119\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03719769131390256\ \(0\)\
\-\ diagnosis\\:\\ 0\\.037091839981196716\ \(0\)\
\-\ present\\:\\ 0\\.036715447595357796\ \(0\)\
\-\ findings\\:\\ 0\\.03531358234333625\ \(0\)\
\-\ images\\:\\ 0\\.033097376592959686\ \(0\)\
\-\ by\\:\\ 0\\.030384957267593302\ \(0\)\
\-\ disease\\:\\ 0\\.030034817912805805\ \(0\)\
\-\ and\\:\\ 0\\.02957052242596917\ \(0\)\
\-\ as\\:\\ 0\\.028744815317051465\ \(0\)\
\-\ of\\:\\ 0\\.02800466108497174\ \(0\)\
\-\ are\\:\\ 0\\.02715057635583514\ \(0\)\
\-\ to\\:\\ 0\\.017887758333270578\ \(0\)\
